Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3996.72% is in line with its 5-year average of -4412.66%, around the middle of its 5-year range (-13118.05%–0.00%).
34.26% above its 12-month average of -6079.49%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7450.29%.
OPERATING MARGIN
-3996.72%
OPERATING MARGIN AVG TTM
-6079.49%
OPERATING MARGIN AVG 3Y
-5670.29%
OPERATING MARGIN AVG 5Y
-4412.66%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+34.26%
CURRENT VS 3Y AVG
+29.51%
CURRENT VS 5Y AVG
+9.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Quantum-Si incorporated
Market Cap
$246.31M
Operating Margin
-3996.72%
TTM Avg
-6079.49%
3Y Avg
-5670.29%
5Y Avg
-4412.66%
Market Cap
$244.06M
Operating Margin
31.45%
TTM Avg
15.72%
3Y Avg
41.80%
5Y Avg
-775.63%
Market Cap
$242.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$242.31M
Operating Margin
N/A
TTM Avg
-7.18%
3Y Avg
-10.59%
5Y Avg
-10.29%
Market Cap
$242.02M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$241.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$240.52M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$240.34M
Operating Margin
-1488.31%
TTM Avg
-4815.32%
3Y Avg
-6115.40%
5Y Avg
-4078.06%
Market Cap
$250.79M
Operating Margin
-13.78%
TTM Avg
-1055.13%
3Y Avg
-2810.33%
5Y Avg
-1873.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $246.31M | -3996.72% | -6079.49% | -5670.29% | -4412.66% |
| Q32 Bio Inc. (QTTB)vs › | $244.06M | 31.45% | 15.72% | 41.80% | -775.63% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | N/A | -7.18% | -10.59% | -10.29% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $241.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Invivyd, Inc. (IVVD)vs › | $240.52M | -103.99% | -400.39% | -200.20% | -133.47% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
| Century Therapeutics, Inc. (IPSC)vs › | $250.79M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $251.29M | -38.88% | -71.50% | -611.78% | -463.72% |
Gross Margin
47.3%
Operating Margin
-3996.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -7450.29% |
| 2026-03-31 | -9322.87% |
| 2025-12-31 | -4677.16% |
| 2025-09-30 | -4419.57% |
| 2025-06-30 | -4527.58% |
| 2025-03-31 | -2982.42% |
| 2024-12-31 | -2573.57% |
| 2024-09-30 | -3569.00% |
| 2024-06-30 | -4252.57% |
| 2024-03-31 | -5111.60% |
| 2023-12-31 | -6970.75% |
| 2023-09-30 | -12186.10% |
| 2023-06-30 | -13118.05% |
| 2023-03-31 | -11504.33% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
